MHRA approves aumolertinib to treat non-small cell lung cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 3 June 2025, approved aumolertinib (Aumseqa) for adult patients with...
NonSmall
Bayer’s sevabertinib gets priority review for treatment of non-small cell lung cancer
Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) and granted...
Non-Small Cell Lung Cancer Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
Renub Research has released a report titled “Non-Small Cell Lung Cancer Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast...
